Figure 6
From: Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
Platinum − DNA binding levels in the ovarian A2780, A2780cisR , A2780ZD0473R and SKOV-3 cancer cell lines due to treatment with CB and OX and their combinations with BORT. Cells were treated with the drugs for 24 h followed by collection, DNA extraction and finally the detection of Pt using AAS. Data were statistically analyzed using the paired Student’s t test: * p <0.05 indicates significant difference from control. Error bars represent the standard deviation.